Biomarkers Market Analysis, Emerging Technologies, Growth Trends, and Forecast, 2013 - 2020

1
Biomarkers Market (Diagnostic Applications in
Risk Assessment, Molecular Diagnostics, Disease
Diagnosis) - Industry Analysis, Emerging
Technologies, Competitive Intelligence, Growth
Trends, Size, Share, Forecast, 2013 - 2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
2
Report Overview
Biomarkers Market 2013-2020, Size, Share, Trends,
Company Profiles, Demand, Insights, Analysis,
Research, Report, Opportunities, Segmentation and
Forecast by Research Beam Biomarker technology
is evidencing increased application from key
segments such as disease diagnosis, drug
development and formulation, diagnosis for
exposure of certain harmful chemical and
prognostic treatments. Biomarkers are novel
diagnostic solutions and advancement in it its
development and understanding of human genome
promotes its application in diagnosis of disease
on molecular basis. Pharmaceutical companies
which are interested in introducing novel
diagnostic solution are increasing partnership
and collaboration with private laboratories,
educational institute and these companies are
also increasing their investments in research and
development.
3
Report Overview
The global market for diagnostic biomarker
expected to reach about 30.6 billion in 2020
growing at CAGR of 16 from 2013 to 2020. Disease
diagnostic application remains the key area of
application that is expected to reach 6.1
billion in 2020. However application of
diagnostic biomarkers in forensics and molecular
diagnostics is catching up quite significantly.
Molecular diagnostics is expected to grow at a
CAGR of 17.6 from 2013 to 2020. SCOPE Global
diagnostic Biomarker report segments the market
in three categories market by technologies,
market by services, and market by diseases. These
markets are expected to show elevated growth in
future as biomarkers are providing diagnostic
service for complex disease. As it is
non-invasive procedure it motivates the use of
biomarkers than conventional diagnostic
applications.
4
Report Overview
KEY DELIVERABLES Biomarkers of disease are
majorly covered by oncology, cardiovascular and
Neurology disease. Oncology biomarkers are
covering more market share as compared to other
disease biomarkers. Other biomarker are facing
some ethical and technical problem such complex
sample preparation process. Biomarkers in
service has open a new market for sample
preparation for disease diagnosis which enables
clinicians to save time required for preparing
sample to conduct diagnostic test. Biomarkers are
also resolving drug validation problem by
analyzing viability of drug discovered by
pharmaceutical research. Enquire about report
_at_ http//www.researchbeam.com/biomarkers-market/e
nquire-about-report
5
Table of Content
CHAPTER 1 INTRODUCTION 1.1 Scope and Coverage 1.2
Report Description CHAPTER 2 EXECUTIVE
SUMMARY 2.1 Biomarker Diagnosis Vs. Conventional
Diagnosis 2.2 Why Diagnostic Biomarkers are Used
in Diagnosis and Drug Development? CHAPTER 3
MARKET OVERVIEW 3.1 Key Application of Diagnostic
Biomarkers in Top Technologies 3.1.1 Omics
Technology 3.1.1.1 Applications of Omics
Technology CHAPTER 4 GLOBAL DIAGNOSTIC BIOMARKER
MARKET BY TYPES, 2013-2020, MILLION 4.1
Biomarker of Exposure 4.2 Biomarkers of Disease
6
(No Transcript)